EMN vs SER · P/E 21, rev $9.38B vs rev $56.0K
Eastman Chemical Company (EMN) versus Serina Therapeutics Inc (SER) — a side-by-side from cached financials, not a winner call.
Eastman Chemical Company (EMN) is a specialty chemicals company listed on US.
Serina Therapeutics Inc (SER) is a biotechnology company listed on AMEX.
Latest reported EMN revenue for 2024-12-31 was $9.38B. Net income was $908.0M. Revenue was up 1.9% from 2023-12-31 to 2024-12-31. EMN currently screens at market cap $8.21B and trailing P/E 20.8.
Latest reported SER revenue for 2024-12-31 was $56.0K. Net income was -$11.2M. Revenue was down 98.2% from 2023-12-31 to 2024-12-31. SER currently screens at market cap $29.7M.
EMN currently screens at market cap $8.21B and trailing P/E 20.8. SER currently screens at market cap $29.7M.
Not investment advice. Open the EMN and SER stock pages for the full models.
Not investment advice.